Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c6a921f33fe0adc58c2b6177184515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
filingDate |
2003-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76eb8948463046a7c61f73b3f8ae15ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7800b89f2cf0bdc2d71535aa21d92fcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e2ba9e50d8763a75ef8ed95488778fe |
publicationDate |
2004-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2004175369-A1 |
titleOfInvention |
Stat3 antagonists and their use as vaccines against cancer |
abstract |
The present invention relates to methods for treating and/or preventing cancer. In particular the present invention relates to ex vivo immunotherapeutic methods. The methods comprise decreasing Stat3 (signal transducer and activator of transcription3) expression and/or function in tumor cells and the administration of such cells to a subject in need of treatment and/or prevention. Other methods of the invention comprise activating T-cells by co-culturing the T-cells with the tumor cells with decreased Stat3 expression or function. The invention further encompasses methods comprising decreasing Stat3 expression or function in antigen-presenting cells and co-administering tumor cells and the antigen-presenting cells with decreased Stat3 function to a patient. The invention further relates to methods for stimulating dendritic cell differentiation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7759510-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006030536-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7951374-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006065894-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006065894-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10000531-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8598230-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2050458-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10813939-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008053805-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008187992-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007031871-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009227489-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006127502-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7763585-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010316704-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011236471-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8455543-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009285884-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007161613-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7977381-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8247445-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133692-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009306035-A1 |
priorityDate |
2003-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |